These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 816588)

  • 1. Ethosuximide dosage regimens.
    Buchanan RA; Kinkel AW; Turner JL; Heffelfinger JC
    Clin Pharmacol Ther; 1976 Feb; 19(2):143-7. PubMed ID: 816588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosuximide in the treatment of absence (peptit mal) seizures.
    Browne TR; Dreifuss FE; Dyken PR; Goode DJ; Penry JK; Porter RJ; White BG; White PT
    Neurology; 1975 Jun; 25(6):515-24. PubMed ID: 805382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal).
    Callaghan N; O'Hare J; O'Driscoll D; O'Neill B; Daly M
    Dev Med Child Neurol; 1982 Dec; 24(6):830-6. PubMed ID: 6818076
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved control of epilepsy by monitoring plasma ethosuximide.
    Sherwin AL; Robb JP; Lechter M
    Arch Neurol; 1973 Mar; 28(3):178-81. PubMed ID: 4631034
    [No Abstract]   [Full Text] [Related]  

  • 5. Once-daily ethosuximide in the treatment of absence epilepsy.
    Dooley JM; Camfield PR; Camfield CS; Fraser AD
    Pediatr Neurol; 1990; 6(1):38-9. PubMed ID: 2106890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethosuximide and bicuculline inhibition in petit mal epilepsy.
    Englander RN; Johnson RN; Hanna GR
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):265-75. PubMed ID: 99676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of treatment in typical absence seizures. The roles of long-term EEG monitoring and ethosuximide.
    Blomquist HK; Zetterlund B
    Acta Paediatr Scand; 1985 May; 74(3):409-15. PubMed ID: 3923777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predicting therapeutic success in the treatment of children with petit mal using a pattern recognition method].
    Iovlev BV; Kharitonov RA; Chelyshev MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(6):77-84. PubMed ID: 6810602
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproic acid versus ethosuximide in the treatment of absence seizures.
    Sato S; White BG; Penry JK; Dreifuss FE; Sackellares JC; Kupferberg HJ
    Neurology; 1982 Feb; 32(2):157-63. PubMed ID: 6798490
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with clinico-electroencephalographic studies on the action of zarontine in petit mal seizures in children].
    Samardzhiev AKh; Sirakov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1544-9. PubMed ID: 4970664
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethosuximide treatment of petit mal seizures. A study of 87 pediatric patients.
    Weinstein AW; Allen RJ
    Am J Dis Child; 1966 Jan; 111(1):63-7. PubMed ID: 4954419
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ethosuximide in treatment of petit mal epilepsy].
    Kiehi Y; Ando J
    No To Shinkei; 1965 Aug; 17(8):831-40. PubMed ID: 4957471
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethosuximide plasma concentrations: influence of age and associated concomitant therapy.
    Battino D; Cusi C; Franceschetti S; Moise A; Spina S; Avanzini G
    Clin Pharmacokinet; 1982; 7(2):176-80. PubMed ID: 6802548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Capparelli EV; Adamson PC;
    N Engl J Med; 2010 Mar; 362(9):790-9. PubMed ID: 20200383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolism and elimination of ethosuximide in neonates whose mothers had petit mal].
    Tejerizo López LC; de Santiago Obeso J; Henríquez Esquiroz JM; Pérez González MC; Jorge Mendoza JM
    An Esp Pediatr; 1987 Nov; 27(5):352-6. PubMed ID: 3125772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of drugs used for petit mal 'absence' epilepsy.
    Eadie MJ; Tyrer JH; Smith GA; McKauge L
    Clin Exp Neurol; 1977; 14():172-83. PubMed ID: 99738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood serotonin in untreated petit-mal epileptics and influence of efficient treatment with either ethosuximide or valproate.
    Volanschi D; Luca N; Haţegan D; Ionescu G
    Neurol Psychiatr (Bucur); 1982; 20(1):67-70. PubMed ID: 6803347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with a combination of ethosuximide and mepacrine (Acrisuxin) in the treatment of chronic epileptic seizures in children].
    Hohenauer I; Schmoigl S
    Padiatr Padol; 1972; 7(4):380-3. PubMed ID: 4628247
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethosuximide pharmacokinetics in a pregnant patient and her newborn.
    Koup JR; Rose JQ; Cohen ME
    Epilepsia; 1978 Dec; 19(6):535-9. PubMed ID: 104867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.